Non-listed drugmakers reluctant to spend on R&D

Published: 2011-05-04 07:00:00

Updated: 2011-05-04 07:00:00

Non-listed Korean manufacturers that chalked up sales of over hundred billion won last year, invested less than 1 percent of their revenue in research.

Yakup Shinmoon said recently that three out of 31 firms with above hundred billion won in sales have been reluctant to spend money on research and development (R&D) projects
Included in the three are SamOh Pharmaceutical, Taejoon Pharmaceuti...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.